Search Results 401-410 of 15781 for syphilis

1. Mayo Clinic to host National Prescription Drug Take Back Day event

   Heather Carlson Kehren, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu · Mayo Clinic Minute: Signs and symptoms of syphilis · Mayo Clinic Q and A ...

2. Francis Baffour, M.D. - Doctors and Medical Staff - Mayo Clinic

   Musculoskeletal MRI — Reviewing MRI images to diagnose disease of the musculoskeletal system; Multiple myeloma imaging — specifically, developing new ...

3. Viji Shridhar, Ph.D. - Doctors and Medical Staff - Mayo Clinic

   2002. Bernard Waterman ScholarMayo Clinic College of Medicine and Science, Department of Education Administration · 1968. Merit ScholarUniversity of Madras ...

4. Rabies - Diagnosis & treatment - Mayo Clinic

   Learn about this deadly virus that most often spreads to people through the bite of an infected animal.

5. Infectious Diseases A–Z: Who is at risk of histoplasmosis infection?

   Histoplasmosis is an infection caused by a fungus or mold that often affects the lungs. In the U.S., it is most common in the Ohio and Mississippi river ...

6. Leukemia - Diagnosis and treatment - Mayo Clinic

   By blocking these abnormalities, targeted drug treatments can cause cancer cells to die. Your leukemia cells will be tested to see if targeted therapy may be ...

7. Sameer A. Parikh, M.B.B.S. - Doctors and Medical Staff - Mayo Clinic

   FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

8. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

   This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...

9. Kemuel L. Philbrick, M.D. - Doctors and Medical Staff - Mayo Clinic

   1992. Fellow - Consultation-Liaison PsychiatryMayo Graduate School of Medicine, Mayo Clinic College of Medicine · 1991. Chief Resident - PsychiatryWilford Hall ...

10. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...